A carregar...
Bevacizumab for acute neurologic deterioration in patients with glioblastoma
AIM: Glioblastoma causes neurologic dysfunction owing to the tumor's location and peritumoral edema. Bevacizumab improves symptoms and steroid dependence, and may rescue glioblastoma patients hospitalized for acute neurologic dysfunction, allowing them to return home for outpatient treatment. M...
Na minha lista:
| Publicado no: | CNS Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136096/ https://ncbi.nlm.nih.gov/pubmed/25054664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.13.40 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|